NL-OMON34862尚未招募3 期
Efficacy and tolerability of Citrus/Cydonia comp.® 1% solution for injection in patients with grass pollen seasonal allergic rhinitis: A randomised, double-blind, placebo-controlled clinical trial - The CiSAR Study
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- Weleda AG
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Written informed consent
- •Age >= 18 and < 60 years.
- •Seasonal AR:
- •-Duration of respective complaints at least 2 years
- •-RAST for grass pollen: >= 2
- •-Suffering from the following nasal symptoms:
- •sneezing, itching nose, nasal obstruction and watery nasal discharge
- •-Severity score of at least two of the four nasal symptoms >= 2; ranging from 0 = not present to 3 = severe.
- •-Suffering from the following non-nasal symptoms: itchy/burning eyes, watery eyes, redness of eyes and itching ears/throat
- •-Severity score of at least two of the four non-nasal symptoms >= 2; ranging from 0 = not present to 3 = severe
- •- The necessity to use antihistamines and/or corticosteroids for treatment of symptoms for at least two previous years
- •- Average Total Symptom Score in the wash-out period >= 9 on days with a pollen count > 20 or use of rescue medication on days with a pollen count > 20;Healthy volunteers:
- •Written informed consent
- •Age >= 18 and < 60 years
- •RAST for seasonal AR related grass and birch pollen = 0
- •No history of seasonal AR symptoms for at least 2 years
排除标准
- •Chronic autoimmune disease such as Diabetes Mellitus type 1, Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis or Crohn*s disease
- •Known hypersensitivity to one of the constituents of Citrus/Cydonia comp.®
- •Participation in a further clinical trial at the same time or within 4 weeks prior to enrolment into this study
- •Previous use of medicinal products containing Citrus and/or Cydonia
- •Pregnancy or lactation
- •Severe internal or systemic disease (e.g. cardiac, hepatic, renal diseases)
- •A known history of drug, alcohol and/or medication dependence or addiction
- •Immunotherapy in the last two years
- •Other allergies (non seasonal allergies);Healthy volunteers:
- •Nasal seasonal AR related symptoms during the pollen season: sneezing, itching nose, nasal obstruction and watery nasal discharge
- •Chronic inflammatory autoimmune disease such as Diabetes Mellitus type 1, Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis or Crohn*s disease
- •Participation in a further clinical trial at the same time or within 4 weeks prior to enrolment into this study.
- •Pregnancy or lactation
- •Severe internal or systemic disease ( e.g. cardiac, hepatic, renal diseases)
- •A known history of drug, alcohol and/or medication dependence or addiction
- •Immunotherapy in the last two years
- •Other allergies (no seasonal AR)
研究者
相似试验
进行中(未招募)
不适用
Efficacy and tolerability of Citrus/Cydonia comp.® 1% solution for injection in patients with grass pollen seasonal allergic rhinitis: A randomised, double-blind, placebo-controlled clinical trial - The CiSAR StudyGrass pollen allergic rhinitisEUCTR2009-018112-26-NLWeleda AG120
已完成
3 期
Efficacy and tolerability of Citrus/Cydonia comp.® solution for injection in patients with grass pollen seasonal allergic rhinitis: Randomised, double-blind, placebo-controlled comparative clinical trial with three parallel treatment groupshay fevergrass pollen allergy10001708NL-OMON40456Hogeschool Leiden126
招募中
不适用
The CiSAR Studygrass pollenseasonal allergic rhinitisHooikoorts (graspollen)NL-OMON27660ectoraat Antroposofische GezondheidszorgHogeschool LeidenCluster ZorgZernikedreef 11 (D0.036)Postbus 382, 2300 AJ LEIDENT: +31 71 51 88 769M: +31 6 468 468 04120
进行中(未招募)
不适用
EFFECTIVENESS AND TOLERABILITY OF TREATMENT WITH CABERGOLINE IN PATIENTS WITH CUSHING S SYNDROME - CABERGOLINE IN CUSHING S SYNDROMECushing syndromeMedDRA version: 9.1Level: LLTClassification code 10011652Term: Cushing's syndromeEUCTR2006-005218-11-ITASSOCIAZIONE ITALIANA ENDOCRINOLOGIA-METABOLISMO-IPOFISI
尚未招募
2 期
The Effect of Citrus Aurantium distillate on Anxiety and Sleep Disorder in mothers with neonate admitted to neonatal intensive care unitCondition 1: Sleep Disorders. Condition 2: Anxiety.Other sleep disordersAnxiety disorder due to known physiological conditionG47.8F06.4IRCT20201209049666N1Babol University of Medical Sciences60
